Figures computed from official regulatory filings — .
Statistical track record
Free accountWin rates, median returns and the proven-insider analysis come with a free account.
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
NeueHealth, Inc.Listing unverified | BuyD (derivative) | n/a (No price was disclosed in the filing) | Cluster | SEC | |
NeueHealth, Inc.Listing unverified | BuyD (derivative) | n/a (No price was disclosed in the filing) | ClusterFirst in 12mo | SEC | |
Akouos, Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
Trevi Therapeutics, Inc.Listing on record | Buy | $5M | conv 42ClusterFirst in 12mo | SEC | |
GENOCEA BIOSCIENCES, INC.Listing unverified | BuyD (derivative) | $409.7K | ClusterUnusual size+1 | SEC | |
GENOCEA BIOSCIENCES, INC.Listing unverified | Buy | $7.1M | conv 50ClusterFirst in 12mo | SEC | |
Mirum Pharmaceuticals, Inc.Listing on record | Buy | $6.8M | conv 41Cluster | SEC | |
Mirum Pharmaceuticals, Inc.Listing on record | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Mirum Pharmaceuticals, Inc.Listing on record | Other | n/a (No price was disclosed in the filing) | SEC | ||
Trevi Therapeutics, Inc.Listing on record | Buy | $10M | conv 61ClusterFirst in 12mo | SEC | |
Trevi Therapeutics, Inc.Listing on record | Buy | $15M | conv 61ClusterFirst in 12mo | SEC | |
Trevi Therapeutics, Inc.Listing on record | Other | n/a (No price was disclosed in the filing) | SEC | ||
Trevi Therapeutics, Inc.Listing on record | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |